Recombinant SALL-4 (Metastatic Germ Cell Tumor Marker) Antibody [SALL4/12807R]

In Stock
Catalog Number Formulation Size Price
57167-RBM6-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
57167-RBM6-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
57167-RBM6-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol Note
Immunohistochemistry (IHC)
1-2ug/ml
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes

Summary

Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells.

Product Properties & Targets

Host
Rabbit
Applications
Species Reactivity
Isotype / Light Chain
IgG / Kappa
Cellular Localization
Cytoplasm, Nucleus
Gene Name
Positive Control
Expressed in testis
Immunogen
Recombinant fragment (around aa 238-261) of human SALL4 protein
Alternate Names
Sal-like protein 4, DRRS|HSAL4|IVIC|ZNF797

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
SALL4/12807R
Chromosome Location
20q13.2
Mol. Weight of Antigen
112.23kDa
Purification
Protein A

Functions

  • Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab produced in a mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK